Anmeldung erfolgt in Kürze...
Details werden geladen...
GIP/GLP-1 Ups Beta-Cell Function, Insulin Sensitivity in T2D
Data help explain the improved glycemic control seen in the first 2 years of SURPASS-EARLY.
Ähnliche Seiten
Retatrutide Yields Significant Weight Loss in T2D
https://www.medscape.com/viewarticle/retatrutide-yields-significant-weight-loss-t2d-2026a10010n0Type 1 Diabetes Overall, Type 2 Diabetes in Kids on the Rise
https://www.medscape.com/viewarticle/type-1-diabetes-overall-type-2-diabetes-kids-rise-2026a10010dqEloraTZP Boosts Weight Loss, A1c Reduction in T2D
https://www.medscape.com/viewarticle/eloralintide-tirzepatide-combination-drives-greater-weight-2026a10010s0SURPASS-CVOT Looks Beyond the Heart: Tirzepatide Signals Benefits in Infection Mortality, Patient-Reported Outcomes
https://www.medscape.com/viewarticle/surpass-cvot-looks-beyond-heart-tirzepatide-signals-benefits-2026a10010mv